Case Reports
Vol. 3 No. 1 (2011): Reviews, Articles, Case Reports and Letters

Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: January 4, 2011
18663
Views
1065
Downloads
16959
HTML

Authors

Primary illness with cytomegalovirus leads to latent infection with possible reactivations especially in the immunocompromised patients. Toxic epidermal necrolysis is an immune mediated cytotoxic reaction.

A fifty years old female diabetic hypertensive patient with end stage renal disease was admitted with fever of unknown origin, constitutional symptoms, vague upper gastrointestinal symptoms and skin rash. Upper gastrointestinal endoscopic biopsy confirmed her diagnosis with cytomegalovirus esophagitis and duodenitis. Cytomegalovirus immunoglobulin M and immunoglobulin G levels were negative but polymerase chain reaction showed fulminant viremia. Biopsy of the skin rash was consistent with toxic epidermal necrolysis. Despite treatment with Ganciclovir, intravenous immunoglobulins, and granulocyte colony stimulating factor the patient’s condition rapidly deteriorated and she died due to multiorgan failure, disseminated intravascular coagulopathy and overwhelming sepsis.

Probably there is a true association linking toxic epidermal necrolysis to fulminant reactivation of cytomegalovirus. The aim of this anecdote is reporting a newly recognized presentation of cytomegalovirus.

Downloads

Download data is not yet available.

Citations

How to Cite



“Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis”. (2011) Mediterranean Journal of Hematology and Infectious Diseases, 3(1), p. e2011004. doi:10.4084/mjhid.2011.004.